GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,000 | -24.1% | 1,005 | -23.3% | 0.01% | -22.2% |
| Q4 2021 | $58,000 | +13.7% | 1,311 | -1.9% | 0.01% | -30.8% |
| Q3 2021 | $51,000 | +2.0% | 1,337 | +6.4% | 0.01% | +18.2% |
| Q2 2021 | $50,000 | +85.2% | 1,256 | +67.9% | 0.01% | +83.3% |
| Q1 2021 | $27,000 | -44.9% | 748 | -43.7% | 0.01% | -50.0% |
| Q4 2020 | $49,000 | +14.0% | 1,329 | +16.5% | 0.01% | 0.0% |
| Q3 2020 | $43,000 | -42.7% | 1,141 | -38.0% | 0.01% | -45.5% |
| Q2 2020 | $75,000 | -22.7% | 1,841 | -28.2% | 0.02% | -40.5% |
| Q1 2020 | $97,000 | -57.1% | 2,565 | -46.8% | 0.04% | -53.2% |
| Q4 2019 | $226,000 | +7.1% | 4,820 | -2.4% | 0.08% | -1.2% |
| Q3 2019 | $211,000 | +26.3% | 4,940 | +18.4% | 0.08% | +25.0% |
| Q2 2019 | $167,000 | +0.6% | 4,174 | +4.9% | 0.06% | -3.0% |
| Q1 2019 | $166,000 | +48.2% | 3,978 | +34.8% | 0.07% | +20.0% |
| Q4 2018 | $112,000 | – | 2,950 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |